Crinetics Pharmaceuticals
Trade Crinetics Pharmaceuticals 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About CRNX
Crinetics Pharmaceuticals, Inc. operates as a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. The firm's product candidate, CRN00808, is an oral nonpeptide somatostatin agonist for the treatment of acromegaly.
CRNX Key Statistics
Stock Snapshot
As of today, Crinetics Pharmaceuticals(CRNX) shares are valued at $42.23. The company's market cap stands at 4.45B, with a P/E ratio of -8.23.
During the trading session on 2026-07-05, Crinetics Pharmaceuticals(CRNX) shares reached a daily high of $42.42 and a low of $39.83. At a current price of $42.23, the stock is +6.0% higher than the low and still -0.4% under the high.
Trading volume for Crinetics Pharmaceuticals(CRNX) stock has reached 2.18M, versus its average volume of 1.72M.
The stock's 52-week range extends from a low of $25.83 to a high of $57.99.
The stock's 52-week range extends from a low of $25.83 to a high of $57.99.
CRNX News
...
Crinetics Pharmaceuticals recently presented Phase 2 TouCAHn data showing atumelnant reduced glucocorticoid doses while maintaining androgen control in classic...
Analyst ratings
94%
of 17 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.